Today: 22 March 2026
Browse Category

Stock Market 12 January 2026

Applied Materials stock rises on Susquehanna upgrade as chip gear spending call widens

Applied Materials stock rises on Susquehanna upgrade as chip gear spending call widens

Applied Materials rose 1.7% to $306.35 in early New York trading after Susquehanna upgraded the stock to Positive and raised its price target to $400. The move followed analyst Mehdi Hosseini’s report citing stronger wafer fab equipment demand and higher semiconductor capital spending. The S&P 500 and Nasdaq-100 slipped, while other chip equipment stocks saw modest gains.
Eli Lilly stock edges up as $1 billion Nvidia AI lab plan hits JPM spotlight

Eli Lilly stock edges up as $1 billion Nvidia AI lab plan hits JPM spotlight

Eli Lilly shares rose about 0.7% Monday after announcing a $1 billion, five-year AI drug discovery lab partnership with Nvidia. The Bay Area facility, using Nvidia’s Vera Rubin chips, will open in March with teams from both firms. Investors are watching for updates from CEO David Ricks at the J.P. Morgan Healthcare Conference on Tuesday and Lilly’s earnings call on Feb. 4.
Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health shares fell about 9% Monday after announcing a U.S. licensing deal with Future Pak for exclusive rights to Mytesi and Canalevia-CA1, potentially worth up to $38 million. The stock traded between $0.94 and $1.45 on heavy volume. Jaguar will receive $18 million upfront and may get up to $20 million more in milestone payments, while shifting its U.S. commercial focus to Future Pak.
12 January 2026
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna shares fell 4% to $32.92 Monday after the company raised its 2025 revenue forecast to $1.9 billion and projected operating expenses of up to $5.2 billion. CFO Jamey Mock said U.S. retail vaccination rates dropped 26% in 2025. The company expects about $8.1 billion in year-end cash, including $600 million from a new loan. Investors remain cautious as pandemic demand fades and late-stage vaccine trial results approach.
Silver price stock SLV jumps nearly 7% as Fed probe headlines push silver to fresh records

Silver price stock SLV jumps nearly 7% as Fed probe headlines push silver to fresh records

Spot silver jumped above $85 an ounce Monday, triggering a 6.9% surge in iShares Silver Trust (SLV) to $77.40 on heavy volume. The rally followed news of grand jury subpoenas for Fed Chair Jerome Powell, raising concerns about central bank independence and weakening the dollar. Traders are watching for Tuesday’s U.S. CPI data and the Fed’s late-January meeting.
Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,

Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,

Vistra launched a private sale of senior secured notes maturing in 2031 and 2036 to fund its $4.7 billion acquisition of Cogentrix Energy and repay debt. The notes will be issued by Vistra Operations Company LLC and backed by subsidiary guarantees and collateral. Shares rose about 2.6% to $170.71 in early trading. The company has not disclosed the offering’s size or interest rates.
12 January 2026
Google Gemini adds Walmart checkout: Alphabet’s new AI shopping push puts GOOGL stock in focus

Google Gemini adds Walmart checkout: Alphabet’s new AI shopping push puts GOOGL stock in focus

Walmart shoppers can now find and buy products directly through Google’s Gemini assistant, following a new integration announced Monday. Google also launched an open Universal Commerce Protocol to link AI agents with retailer checkout systems. Walmart shares rose about 2% in early trading, while Alphabet slipped 0.4%. Shopify said its merchants will soon sell through Google’s AI platforms as the rollout expands.
Bitcoin price holds near $91,000 after Strategy’s $1.25 billion buy; crypto stocks mixed

Bitcoin price holds near $91,000 after Strategy’s $1.25 billion buy; crypto stocks mixed

Bitcoin rose 0.4% to $91,164 Monday after Strategy disclosed a $1.25 billion purchase of 13,627 bitcoin, bringing its holdings to 687,410. U.S.-listed crypto stocks were mixed in early trading. Traders focused on Tuesday’s U.S. CPI report and fallout from DOJ subpoenas of Fed Chair Powell. ETF outflows and dollar moves added to market volatility.
Dow Jones ETF drops as Trump’s credit-card cap plan and Fed subpoena fight hit banks

Dow Jones ETF drops as Trump’s credit-card cap plan and Fed subpoena fight hit banks

The Dow-linked DIA fell about 0.5% Monday morning, pressured by declines in financial stocks after President Trump proposed capping credit-card rates at 10%. Tensions rose as the White House threatened Fed Chair Powell with indictment over Senate testimony, which Powell called a “pretext.” Traders are watching Tuesday’s U.S. CPI report and big-bank earnings for further direction.
Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

Duolingo shares fell about 7% Monday after CFO Matt Skaruppa announced his departure, with board member Gillian Munson set to replace him Feb. 23. The company reported a 30% year-over-year jump in daily active users and bookings at or above the top of its forecast for Q4. Munson’s base salary will be $800,000 plus $14 million in stock units. Skaruppa will stay on as an adviser, earning $32,292 a month.
12 January 2026
Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Teva shares rose about 4% to $33.29 after announcing a funding deal with Royalty Pharma worth up to $500 million for its experimental vitiligo drug. An SEC filing previewed Teva’s 2025 outlook, including projected revenue of $16.8–$17.0 billion and adjusted EBITDA of $4.8–$5.0 billion. Investors await more details at Tuesday’s J.P. Morgan Healthcare Conference.
Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus

Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus

Oracle shares edged up 0.2% to $198.96 after Goldman Sachs initiated coverage with a Buy rating and $240 target. The stock remains down over 40% since September amid concerns over debt tied to AI data-center expansion. Oracle reported a 438% surge in backlog to $523 billion in Q2. On Sunday, it launched a new retail cloud platform at NRF 2026 in New York.
SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

Sun Country shares jumped nearly 13% after Allegiant agreed to buy the airline in a $1.5 billion cash-and-stock deal. Allegiant shares fell 4% as investors weighed integration risks and deal costs. The offer values Sun Country at $18.89 per share, a 19.8% premium. Traders are watching the antitrust review and fluctuations in Allegiant’s stock, which affect the deal’s final value.
GOOG stock slips as Google’s Gemini adds “buy” checkout with Walmart — what to watch next

GOOG stock slips as Google’s Gemini adds “buy” checkout with Walmart — what to watch next

Alphabet Class C shares fell 0.5% to $327.60 Monday after Google launched new shopping and checkout features for its Gemini app with Walmart and other retailers. The move comes as Google pushes agent-led commerce and unveils a new Universal Commerce Protocol. Broader U.S. markets edged down, with the S&P 500 ETF and Invesco QQQ each slipping 0.1%.
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

Synchrony Financial shares dropped about 7% to $80.80 Monday after President Donald Trump called for a one-year 10% cap on credit-card interest rates starting Jan. 20. Other credit-card lenders also fell. Trump gave no details on enforcement, and analysts questioned whether the proposal could pass Congress. Investors are watching for any movement as bank earnings season begins.
12 January 2026
Meta stock dips as Zuckerberg taps Dina Powell McCormick as president — what investors watch next

Meta stock dips as Zuckerberg taps Dina Powell McCormick as president — what investors watch next

Meta shares slipped 0.1% to $652.24 after the company named Dina Powell McCormick president and vice chairman. CEO Mark Zuckerberg said she will lead efforts to finance and expand Meta’s AI and infrastructure. Investors remain cautious amid global regulatory pressures and concerns over rising costs. Powell McCormick resigned from Meta’s board weeks earlier.
12 January 2026
Sandisk (SNDK) stock rebounds after early dip as AI memory shortage talk keeps traders buying

Sandisk (SNDK) stock rebounds after early dip as AI memory shortage talk keeps traders buying

Sandisk shares rose 2.9% to $388.33 in early Monday trading after an earlier 5.1% drop, as investors tracked AI-driven storage demand and supply constraints. The stock moved between $358 and $389.35. Investors await Sandisk’s Jan. 29 earnings call for updates on pricing and outlook. Western Digital edged up 0.3%, while Micron slipped 0.5%.

Stock Market Today

  • Tech Stocks The Trade Desk and Axon Enterprise Poised for Long-Term Growth
    March 22, 2026, 3:41 AM EDT. The Trade Desk and Axon Enterprise present compelling investment opportunities in the tech sector. The Trade Desk, a player in the digital advertising market projected to exceed $950 billion by 2026, offers a customer-centric ad buying platform that has maintained a 95% client retention rate over 12 years. Despite a slowdown impacting sectors like consumer goods and automotive, The Trade Desk trades at a significant discount with a price-to-earnings ratio of 11, signaling potential for robust returns. Axon Enterprise is expanding beyond its Taser products into a tech platform integrating body cameras, drones, cloud software, and AI for law enforcement. Both companies are well placed in growth markets, with current stock prices below recent highs, presenting a possible entry point for patient investors seeking exposure to innovative, growth-oriented tech businesses.
Go toTop